| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
26 |
| Employees |
37 |
| Revenues (TTM) (Millions $) |
25 |
| Net Income (TTM) (Millions $) |
-32 |
| Cash Flow (TTM) (Millions $) |
-22 |
| Capital Exp. (TTM) (Millions $) |
3 |
Business Description
Novan Inc is a biotechnology company that specializes in the development and commercialization of innovative therapies for dermatological conditions. The company focuses on leveraging nitric oxide's natural antimicrobial and anti-inflammatory properties to create novel and differentiated products for various skin conditions.
Novan's proprietary technology platform, known as Nitricil, harnesses the power of nitric oxide to penetrate and disrupt biofilms in the skin, which can often lead to chronic and treatment-resistant infections. This technology has potential applications in areas such as acne, warts, onychomycosis (nail fungal infections), and molluscum contagiosum.
The company's lead product candidate, SB206, is being developed for the treatment of molluscum contagiosum, a common skin viral infection that primarily affects children. Novan has also ventured into the development of nitric oxide-based therapies for other indications, including genital warts and inflammatory skin diseases like psoriasis.
Novan Inc has formed partnerships with various organizations to support the development and marketing of its products. The company has a collaborative agreement with Sato Pharmaceutical for the development and commercialization of SB204 and SB206 products in Japan. Novan is also engaged in preclinical research and development projects to explore the therapeutic potential of its Nitricil platform in other indications.
Overall, Novan Inc is a biotechnology company striving to bring innovative and effective therapies to patients with dermatological conditions by utilizing the unique properties of nitric oxide.
Company Address: 4020 Stirrup Creek Drive, Suite 110 Durham, 27703 NC
Company Phone Number: 485-8080 Stock Exchange / Ticker: NASDAQ NOVN
|
%
0.13%